Provenance
Created by SPS, the British Association for Sexual Health and HIV (BASHH), the British Association of HIV (BHIVA) and the support of specialist stakeholders working within clinical practice for sexual health services.
Published versions
Version 3.0 of this PGD template, valid from November 2026, has been published to allow organisations to undertake local governance processes in a timely manner.
Version 2.0 of this PGD template remains currently valid and will be removed from this page on its expiry (31st October 2026).
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).
More sexual health PGD templates
- Fluconazole 150mg capsules for candidiasis
- Clotrimazole cream for candidiasis and candidal balanoposthitis
- Metronidazole (oral) for use within sexual health services
- Ceftriaxone intramuscular injection for Neisseria gonorrhoeae
- Emtricitabine and tenofovir disoproxil (TD) tablets as PrEP
- Doxycycline for use within sexual health services
- Azithromycin (oral) for use within sexual health services
- Doxycycline post exposure prophylaxis (doxyPEP)
- Emtricitabine/tenofovir and raltegravir tablets for HIV PEP
- Podophyllotoxin (topical) for external anogenital warts
- Imiquimod 5% w/w cream for anogenital warts
- Emtricitabine and tenofovir alafenamide (TAF) tablets as PrEP
- Aciclovir (oral) for genital HSV infection
All PGD templates
National PGD, protocol and written instructions templates
National templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
Update history
- Republished
- PGD template Version 3.0 published
- Republished
- PGD template attachment replaced with new accessible version.
- Version 1 removed as expiring end Oct 23.
- Version 2.0 published
- Title, URL and summary amended.
- Published